Seroprevalence of Hepatitis A Infection in the Turkish Republic of Northern Cyprus

Basit Öğe Kaydı
dc.contributor.authorKurugol, Zafer
dc.contributor.authorKoturoglu, Gueldane
dc.contributor.authorAksit, Sadik
dc.contributor.authorOzacar, Tijen
dc.date.accessioned2019-10-27T20:19:32Z
dc.date.available2019-10-27T20:19:32Z
dc.date.issued2009
dc.departmentEge Üniversitesien_US
dc.description.abstractAims: This study was conducted to determine the seroprevalence of hepatitis A virus (HAV) infection in the Turkish Republic of Northern Cyprus. Materials and Methods: A total of 660 unvaccinated persons 1 to 30 years old were selected for the study with cluster sampling. Information on sociodemographic characteristics was gathered for each participant and, in 641 of them, anti-HAV antibodies were assayed using an enzyme immune assay. Results: Anti-HAV prevalence in the Turkish population under the age of 30 in Northern Cyprus was 23.9%. For the age groups 1-5, 6-10 and 11-15 years, seroprevalence rates were relatively low (11.4, 9.4 and 12%, respectively). For age groups 16 years and over. HAV seroprevalence gradually increased with age, rising to 30.4% in 16 to 20 years and to 52.5% in 21 to 30 years of age. In addition to age, other variables significantly associated with HAV seroprevalence included low family income, family size, waste water sewage, and the education level of parents. Conclusions: Anti-HAV seroprevalence in the Turkish Republic of Northern Cyprus shows an intermediate prevalence. As well as expanding health education and improving sanitation. a hepatitis A universal mass vaccination program would be logical for the population.en_US
dc.description.sponsorshipTurkish Republic of Northern Cyprus Hepatitis A Study Teamen_US
dc.description.sponsorshipThe authors would like to acknowledge the Turkish Republic of Northern Cyprus Hepatitis A Study Team (Dr. Sidika Kayimbasoglu, Dr. Sonay Ozbalikci, Dr. Gulten Ercal, Dr. Emine Gulluelli, Dr. Figen Bakkaloglu, Dr. Ertan Dogan, Dr. Hasan Garabli, Dr. Huseyin Erical, Dr. Cemal Mert and Dilek Aslan) for their help and cooperation.en_US
dc.identifier.endpage113en_US
dc.identifier.issn1300-0144
dc.identifier.issn1300-0144en_US
dc.identifier.issue1en_US
dc.identifier.startpage109en_US
dc.identifier.urihttps://hdl.handle.net/11454/41452
dc.identifier.volume39en_US
dc.identifier.wosWOS:000264805800019en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherTubitak Scientific & Technical Research Council Turkeyen_US
dc.relation.ispartofTurkish Journal of Medical Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHepatitis Aen_US
dc.subjectseroprevalenceen_US
dc.subjectTurkish Republic of Northern Cyprusen_US
dc.titleSeroprevalence of Hepatitis A Infection in the Turkish Republic of Northern Cyprusen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu